| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8721481 | Clinical Immunology | 2017 | 42 Pages |
Abstract
These results provide additional support for the role of macrophages as a potentially valuable therapeutic target in SLE. Inhibiting CSF-1 receptor signaling would be more targeted than current immunosuppressive therapies, and may hold promise for the treatment of renal and neuropsychiatric end organ disease manifestations.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Samantha A. Chalmers, Jing Wen, Justine Shum, Jessica Doerner, Leal Herlitz, Chaim Putterman,